Author

David Adeleke

North Dakota State UniversityORCID 0000-0002-4212-8745Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

David Adeleke2 papers · Cincinnati Children's Hospital Medical Center

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Organism:human· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Adewale Oluwaseun FadakaiD· 1 shared Ashwil KleiniD· 1 shared Gomes Rahul· 1 shared Mervin MeyeriD· 1 shared Nicole Remaliah Samantha SibuyiiD· 1 shared Rick J. JanseniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Adewale Oluwaseun FadakaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioinformaticsTranslational OncologyPeer-reviewedFeb 3, 2026

AlphaMissense pathogenicity scores predict response to immunotherapy and enhances the predictive capability of tumor mutation burden

David Adeleke, Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi…·Rick J. Jansen

The paper introduces AlphaTMB, a composite biomarker combining tumor mutation burden with pathogenicity scores, showing improved survival prediction in immunotherapy response.

DOI 10.1016/j.tranon.2026.102697

humanwhole-exome sequencing